2026 Stefan H. Hohnloser: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	126	2868	2676	149	144	716	105127

Stefan H. Hohnloser publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stefan H. Hohnloser sits on this spectrum.

101 publications 1,796+

This scientist: 716 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stefan H. Hohnloser D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stefan H. Hohnloser sits on this spectrum.

70 D-Index 217+

This scientist: 126 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stefan H. Hohnloser is affiliated with Goethe University Frankfurt in Germany and specializes primarily in Medicine with a focus on Cardiology and Cardiovascular Medicine. Their scholarly output includes significant contributions to subfields such as Radiology, Nuclear Medicine and Imaging, Internal Medicine, Epidemiology, and Economics and Econometrics.

The main topics of Stefan H. Hohnloser's research include:

Atrial Fibrillation Management and Outcomes
Cardiac Arrhythmias and Treatments
Cardiac electrophysiology and arrhythmias
Antiplatelet Therapy and Cardiovascular Diseases
Cardiac Imaging and Diagnostics
Cardiac pacing and defibrillation studies
Venous Thromboembolism Diagnosis and Management

Their frequent coauthors reflect a collaborative research network, including:

Jeff S. Healey
Stuart J. Connolly
Jonas Oldgren
A. John Camm
Gregory Y.H. Lip

Stefan H. Hohnloser's research has been published repeatedly in major cardiovascular journals. The most frequent publication venues are:

EP Europace
European Heart Journal
Circulation
Journal of the American College of Cardiology
European Heart Journal - Cardiovascular Pharmacotherapy

Notable recent papers include:

"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation" (2023) - New England Journal of Medicine
"Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial" (2020) - Circulation
"The Increasing Role of Rhythm Control in Patients With Atrial Fibrillation" (2022) - Journal of the American College of Cardiology
"Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease" (2020) - Circulation
"Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference" (2020) - EP Europace

Best Publications

Apixaban versus Warfarin in Patients with Atrial Fibrillation

Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

10588
Citations
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson

9080
Citations
2012 focused update of the ESC Guidelines for the management of atrial fibrillation

A. John Camm;Gregory Y.H. Lip

4444
Citations
Apixaban in Patients with Atrial Fibrillation

Stuart J. Connolly;John Eikelboom;Campbell Joyner;Hans-Christoph Diener

3243
Citations
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.

Stuart J. Connolly;Janice Pogue;Robert G. Hart;Stefan H. Hohnloser

3157
Citations
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

S Connolly;J Pogue;R Hart

2732
Citations
Subclinical Atrial Fibrillation and the Risk of Stroke

Jeff S. Healey;Stuart J. Connolly;Michael R. Gold;Carsten W. Israel

2271
Citations
Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart Failure

Anthony S. L. Tang;George A. Wells;Mario Talajic;Malcolm O. Arnold

2102
Citations
Rhythm control versus rate control for atrial fibrillation and heart failure

Denis Roy;Mario Talajic;Stanley Nattel;D. George Wyse

1987
Citations
Prophylactic Use of an Implantable Cardioverter-Defibrillator After Acute Myocardial Infarction

Stefan H. Hohnloser;Karl Heinz Kuck;Paul Dorian;Robin S. Roberts

1808
Citations
Rhythm or rate control in atrial fibrillation-pharmacological intervention in atrial fibrillation (PIAF): a randomised trial

S Hohnloser;K.H Kuck;J Lilienthal

1802
Citations
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

John W. Eikelboom;Lars Wallentin;Stuart J. Connolly;Mike Ezekowitz

1518
Citations
Effect of dronedarone on cardiovascular events in atrial fibrillation.

Stefan H. Hohnloser;Martin van Eickels;Christophe Gaudin;Richard L. Page

1451
Citations
Guidelines on management (diagnosis and treatment) of syncope

Michele Brignole;P. Alboni;D. Benditt;L. Bergfeldt

1345
Citations
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.

Christopher P. Cannon;Deepak L. Bhatt;Jonas Oldgren;Gregory Y.H. Lip

1257
Citations
2012 Focused Update of the ESC Guidelines for the Management of Atrial Fibrillation

A. John Camm;Gregory Y.H. Lip;Raffaele De Caterina;Irene Savelieva

1026
Citations
Comparison of β-Blockers, Amiodarone Plus β-Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators: The OPTIC Study: A Randomized Trial

Stuart J. Connolly;Paul Dorian;Robin S. Roberts;Michael Gent

874
Citations
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

Bramah N. Singh;Stuart J. Connolly;Denis Roy;Peter R. Kowey

872
Citations
Guidelines on management (diagnosis and treatment) of syncope-update 2004. Executive Summary.

Michele Brignole;Paolo Alboni;David G. Benditt;Lennart Bergfeldt

833
Citations
Guidelines on management (diagnosis and treatment) of syncope--update 2004.

Paolo Alboni;David G. Benditt;Lennart Bergfeldt;Jean-Jacques Blanc

832
Citations

Frequent Co-Authors

Stuart J. Connolly McMaster University

Gregory Y.H. Lip University of Liverpool

Jeff S. Healey Population Health Research Institute

Lars Wallentin Uppsala University

Paulus Kirchhof University of Birmingham

Thomas Meinertz Universität Hamburg

Christopher B. Granger Duke University

John W. Eikelboom Population Health Research Institute

Renato D. Lopes Duke University

Isabelle C. Van Gelder University Medical Center Groningen

External Links

Personal website of Stefan H. Hohnloser

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

If you’re considering studying Medicine in the USA, there are several online degree options and career pathways worth exploring. For those interested in beginning their healthcare journey quickly, fast track lpn programs offer a streamlined path to becoming a Licensed Practical Nurse, allowing you to enter the workforce faster.

For students drawn to mental health, advanced practice roles like Psychiatric Mental Health Nurse Practitioner are in high demand. Completing pmhnp online programs gives you the opportunity to specialize while benefiting from online study flexibility.

If healthcare leadership interests you, many accredited universities offer the cheapest online healthcare administration degree, making this pathway affordable and accessible. For further advancement, a graduate degree is often necessary. Understanding the masters in healthcare administration cost can help you budget effectively while seeking higher-level roles.

Exploring these online programs can open doors to rewarding careers in nursing, mental health, or healthcare management — all crucial sectors within the U.S. healthcare system.